BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16620920)

  • 21. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
    Orejuela D; Jorquera R; Bergeron A; Finegold MJ; Tanguay RM
    J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice.
    McCall TD; Pedone CA; Fults DW
    Cancer Res; 2007 Jun; 67(11):5179-85. PubMed ID: 17545597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
    Omidvar N; Kogan S; Beurlet S; le Pogam C; Janin A; West R; Noguera ME; Reboul M; Soulie A; Leboeuf C; Setterblad N; Felsher D; Lagasse E; Mohamedali A; Thomas NS; Fenaux P; Fontenay M; Pla M; Mufti GJ; Weissman I; Chomienne C; Padua RA
    Cancer Res; 2007 Dec; 67(24):11657-67. PubMed ID: 18089795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes.
    Ma Q; Li X; Vale-Cruz D; Brown ML; Beier F; LuValle P
    J Cell Biochem; 2007 May; 101(2):477-87. PubMed ID: 17219413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury.
    Tehranian R; Rose ME; Vagni V; Griffith RP; Wu S; Maits S; Zhang X; Clark RS; Dixon CE; Kochanek PM; Bernard O; Graham SH
    Brain Res; 2006 Jul; 1101(1):126-35. PubMed ID: 16782076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
    Beirowski B; Weber M; Gross O
    J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ncx (Enx, Hox11L.1) is required for neuronal cell death in enteric ganglia of mice.
    Aoki T; Jusuf AA; Iitsuka Y; Isono K; Tokuhisa T; Hatano M
    J Pediatr Surg; 2007 Jun; 42(6):1081-8. PubMed ID: 17560225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 protects tubular epithelial cells from ischemia/reperfusion injury by dual mechanisms.
    Isaka Y; Suzuki C; Abe T; Okumi M; Ichimaru N; Imamura R; Kakuta Y; Matsui I; Takabatake Y; Rakugi H; Shimizu S; Takahara S
    Transplant Proc; 2009; 41(1):52-4. PubMed ID: 19249473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway.
    Métrailler-Ruchonnet I; Pagano A; Carnesecchi S; Ody C; Donati Y; Barazzone Argiroffo C
    Free Radic Biol Med; 2007 Apr; 42(7):1062-74. PubMed ID: 17349933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia.
    Nakayama K; Nakayama K; Negishi I; Kuida K; Sawa H; Loh DY
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3700-4. PubMed ID: 8170972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune enteropathy in Schimke immunoosseous dysplasia.
    Kaitila I; Savilahti E; Ormälä T
    Am J Med Genet; 1998 Jun; 77(5):427-30. PubMed ID: 9632175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disappearance of polycystic kidney disease in revertant c-myc transgenic mice.
    Trudel M; Chrétien N; D'Agati V
    Mamm Genome; 1994 Mar; 5(3):149-52. PubMed ID: 8199402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Give me liberty or give me an early death.
    Leslie M
    Sci Aging Knowledge Environ; 2002 Jul; 2002(26):nf8. PubMed ID: 14602994
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosing PKD, determining options.
    Steinman T
    Nephrol News Issues; 2006 Mar; 20(3):62, 65. PubMed ID: 16532995
    [No Abstract]   [Full Text] [Related]  

  • 37. bcl-2 to the rescue.
    DeFranco AL
    Curr Biol; 1992 Feb; 2(2):95-7. PubMed ID: 15336006
    [No Abstract]   [Full Text] [Related]  

  • 38. RHEB1 insufficiency in aged male mice is associated with stress-induced seizures.
    Tian Q; Gromov P; Clement JH; Wang Y; Riemann M; Weih F; Sun XX; Dai MS; Fedorov LM
    Geroscience; 2017 Dec; 39(5-6):557-570. PubMed ID: 28891034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tissue dependent interactions between p53 and Bcl-2 in vivo.
    Li X; Miao X; Wang H; Xu Z; Li B
    Oncotarget; 2015 Nov; 6(34):35699-709. PubMed ID: 26452131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the autophagic bcl-2/beclin 1 interaction.
    Decuypere JP; Parys JB; Bultynck G
    Cells; 2012 Jul; 1(3):284-312. PubMed ID: 24710477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.